Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glutamate Receptors in Extinction and Extinction-Based Therapies for Psychiatric Illness
Karyn M. Myers, William A. Carlezon, Michael Davis
Neuropsychopharmacology (2010) Vol. 36, Iss. 1, pp. 274-293
Open Access | Times Cited: 169

Showing 1-25 of 169 citing articles:

Fear Extinction as a Model for Translational Neuroscience: Ten Years of Progress
Mohammed R. Milad, Gregory J. Quirk
Annual Review of Psychology (2011) Vol. 63, Iss. 1, pp. 129-151
Open Access | Times Cited: 1328
Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy
Mark J. Millan, Y. Agid, Martin Brüne, et al.
Nature Reviews Drug Discovery (2012) Vol. 11, Iss. 2, pp. 141-168
Closed Access | Times Cited: 1147
The Nucleus Accumbens: Mechanisms of Addiction across Drug Classes Reflect the Importance of Glutamate Homeostasis
Michael D. Scofield, Jasper A. Heinsbroek, Cassandra D. Gipson, et al.
Pharmacological Reviews (2016) Vol. 68, Iss. 3, pp. 816-871
Open Access | Times Cited: 527
Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders
Nicolas Singewald, Claudia Schmuckermair, Nigel Whittle, et al.
Pharmacology & Therapeutics (2014) Vol. 149, pp. 150-190
Open Access | Times Cited: 375
New medications for drug addiction hiding in glutamatergic neuroplasticity
Peter W. Kalivas, Nora D. Volkow
Molecular Psychiatry (2011) Vol. 16, Iss. 10, pp. 974-986
Open Access | Times Cited: 338
Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options
Amir Garakani, James W. Murrough, Rafael C. Freire, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 304
Rethinking Extinction
Joseph E. Dunsmoor, Yael Niv, Nathaniel D. Daw, et al.
Neuron (2015) Vol. 88, Iss. 1, pp. 47-63
Open Access | Times Cited: 285
Fear extinction and BDNF: translating animal models of PTSD to the clinic
Raül Andero, Kerry J. Ressler
Genes Brain & Behavior (2012) Vol. 11, Iss. 5, pp. 503-512
Open Access | Times Cited: 265
Current diagnosis and treatment of anxiety disorders.
Alexander Bystritsky, Sahib S. Khalsa, Michael Cameron, et al.
PubMed (2013) Vol. 38, Iss. 1, pp. 30-57
Closed Access | Times Cited: 226
Mineralocorticoid and glucocorticoid receptor balance in control of HPA axis and behaviour
Anjanette Harris, Megan C. Holmes, E. R. de Kloet, et al.
Psychoneuroendocrinology (2012) Vol. 38, Iss. 5, pp. 648-658
Closed Access | Times Cited: 217
Neuropharmacological Modulation of N-methyl-D-aspartate, Noradrenaline and Endocannabinoid Receptors in Fear Extinction Learning: Synaptic Transmission and Plasticity
Simone Battaglia, Chiara Di Fazio, Carmelo M. Vicario, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5926-5926
Open Access | Times Cited: 56
Glutamatergic medications for the treatment of drug and behavioral addictions
M. Foster Olive, Richard M. Cleva, Peter W. Kalivas, et al.
Pharmacology Biochemistry and Behavior (2011) Vol. 100, Iss. 4, pp. 801-810
Open Access | Times Cited: 205
New perspectives in glutamate and anxiety
C. Riaza Bermudo-Soriano, M. Mercedes Pérez-Rodríguez, Concepción Vaquero‐Lorenzo, et al.
Pharmacology Biochemistry and Behavior (2011) Vol. 100, Iss. 4, pp. 752-774
Closed Access | Times Cited: 192
Pharmacological treatment of PTSD – Established and new approaches
Thomas Steckler, Victoria B. Risbrough
Neuropharmacology (2011) Vol. 62, Iss. 2, pp. 617-627
Open Access | Times Cited: 175
Pharmacological Treatment of Obsessive-Compulsive Disorder
Christopher Pittenger, Michael H. Bloch
Psychiatric Clinics of North America (2014) Vol. 37, Iss. 3, pp. 375-391
Open Access | Times Cited: 167
Translating Glutamate: From Pathophysiology to Treatment
Daniel C. Javitt, Darryle D. Schoepp, Peter W. Kalivas, et al.
Science Translational Medicine (2011) Vol. 3, Iss. 102
Open Access | Times Cited: 167
Learning to learn – Intrinsic plasticity as a metaplasticity mechanism for memory formation
Megha Sehgal, Chenghui Song, Vanessa L. Ehlers, et al.
Neurobiology of Learning and Memory (2013) Vol. 105, pp. 186-199
Open Access | Times Cited: 151
Deep brain stimulation of the ventral striatum enhances extinction of conditioned fear
Jose Rodríguez-Romaguera, Fabricio H Do Monte, Gregory J. Quirk
Proceedings of the National Academy of Sciences (2012) Vol. 109, Iss. 22, pp. 8764-8769
Open Access | Times Cited: 137
NMDA GluN2A and GluN2B receptors play separate roles in the induction of LTP and LTD in the amygdala and in the acquisition and extinction of conditioned fear
Gemma L. Dalton, Dong Wu, Yu Tian Wang, et al.
Neuropharmacology (2011) Vol. 62, Iss. 2, pp. 797-806
Closed Access | Times Cited: 135
Translating cognition from animals to humans
J.F. Keeler, Trevor W. Robbins
Biochemical Pharmacology (2011) Vol. 81, Iss. 12, pp. 1356-1366
Closed Access | Times Cited: 133
Neuronal mechanisms underlying development of nicotine dependence: implications for novel smoking-cessation treatments.
Manoranjan S. D’Souza, Athina Markou
PubMed (2011)
Closed Access | Times Cited: 126
NMDA receptors and fear extinction: implications for cognitive behavioral therapy
Michael Davis
Dialogues in Clinical Neuroscience (2011) Vol. 13, Iss. 4, pp. 463-474
Open Access | Times Cited: 115
Role of cues and contexts on drug‐seeking behaviour
Christina J. Perry, Isabel Zbukvic, Jee Hyun Kim, et al.
British Journal of Pharmacology (2014) Vol. 171, Iss. 20, pp. 4636-4672
Open Access | Times Cited: 115
HDAC inhibitors as cognitive enhancers in fear, anxiety and trauma therapy: where do we stand?
Nigel Whittle, Nicolas Singewald
Biochemical Society Transactions (2014) Vol. 42, Iss. 2, pp. 569-581
Open Access | Times Cited: 115
Psychological and neural mechanisms of experimental extinction: A selective review
Andrew R. Delamater, R. Frederick Westbrook
Neurobiology of Learning and Memory (2013) Vol. 108, pp. 38-51
Open Access | Times Cited: 114
Page 1 - Next Page

Scroll to top